Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Active not recruiting 6Recruiting 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 1Myeloid 1Lymphoid 1CNS 1

Conditions

Oligodendroglioma 1Neurofibromatosis 1 1Neurofibroma, Plexiform 1Neurocytoma 1Neuroblastoma 1Neoplasms 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Histiocytosis, Langerhans-Cell 1Glioma 1Glioblastoma 1Ganglioneuroma 1Ganglioglioma 1Astrocytoma 1

Interventions

Specimen Handling 116pembrolizumab 112Magnetic Resonance Spectroscopy 99Carboplatin 83Cyclophosphamide 70Biopsy 63Cisplatin 59Paclitaxel 56Bevacizumab 56Gemcitabine 48Nivolumab 45fludarabine 39Dexamethasone 37atezolizumab 36Rituximab 36Pemetrexed 36Fluorouracil 36Docetaxel 35Leucovorin 32Doxorubicin 31venetoclax 30Radiotherapy 30Oxaliplatin 29Capecitabine 29Temozolomide 27Prednisone 26Cetuximab 26130-nm albumin-bound paclitaxel 25Standard of Care 24Letrozole 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × dabrafenib × 30 days × Clear all
NCT03975829 2026-06-02

Pediatric Long-Term Follow-up and Rollover Study

Novartis

Phase 4 Recruiting
165 enrolled
CNSMyeloid

Astrocytoma, Ganglioneuroma, Glioblastoma, Glioma, Histiocytosis, Langerhans-Cell, Neuroblastoma, Neurofibromatosis 1, Oligodendroglioma, Ganglioglioma, Neurocytoma, Neurofibroma, Plexiform

NCT02693535 2026-05-29

TAPUR

American Society of Clinical Oncology

Phase 2 Recruiting
4,200 enrolled
LymphoidPlasma cell

Lymphoma, Non-Hodgkin, Multiple Myeloma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡